Clinical Trials
5
Active:4
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
- First Posted Date
- 2012-04-09
- Last Posted Date
- 2016-03-25
- Lead Sponsor
- Akinion Pharmaceuticals AB
- Target Recruit Count
- 25
- Registration Number
- NCT01573247
- Locations
- 🇨🇿
University Hospital Brno, Brno, Czech Republic
🇨🇿University Hospital Kralovske Vinohrady, Prague, Czech Republic
🇵🇱MTZ Clinical Research Inc., Warsaw, Poland
News
No news found